Cash Flow - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -170.87 | 13.55 | -59.27 | -40.08 | -17.56 | 9.07 | -18.90 | -16.88 |
| Cash flow from investing | 56.77 | -106.10 | -87.18 | -0.20 | -0.06 | -0.92 | -0.10 | -0.45 |
| Cash flow from financing | 104.60 | 72.40 | 6.90 | 190.73 | 53.16 | 5.10 | 8.61 | 19.40 |
| Change in cash | -9.50 | -20.15 | -139.55 | 150.46 | 35.54 | 13.25 | -10.38 | 2.08 |
Show Quarterly Cash Flow
Cash Flow - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -44.95 | -43.49 | -47.05 | -39.59 | -40.74 | 42.00 | -14.47 | -7.28 | -6.71 | -17.41 | -12.76 | -16.67 | -12.43 | -20.50 | -5.68 | -6.97 | -6.93 | -21.31 | -19.12 | -14.14 | -12.20 | -5.44 | -7.63 |
| Cash flow from investing | 27.79 | 24.11 | -44.98 | 48.57 | 29.06 | -101.76 | 16.82 | -12.65 | -8.51 | 26.04 | -46.64 | 44.97 | -111.55 | -0.13 | -0.03 | -0.02 | -0.02 | -25.69 | -40.06 | -0.70 | -0.04 | -0.01 | -0.03 |
| Cash flow from financing | 0.16 | 1.13 | 100.05 | 2.70 | 0.73 | 70.92 | 0.68 | 0.55 | 0.26 | 1.81 | 0.92 | 2.85 | 1.32 | 193.82 | -1.56 | -0.62 | -0.91 | 0.28 | 0.15 | 0.32 | -0.13 | 11.93 | 21.32 |
| Change in cash | -17.00 | -18.24 | 8.02 | 11.68 | -10.95 | 11.16 | 3.03 | -19.38 | -14.97 | 10.44 | -58.49 | 31.16 | -122.66 | 173.20 | -7.27 | -7.62 | -7.85 | -46.72 | -59.03 | -14.52 | -12.36 | 6.49 | 13.65 |